1 hour ago · Hong Kong
Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?
What's happening
SignalsMonitor is following this as a health story. South China Morning Post Asia is the outlet attached so far. The reports are tied to Hong Kong. The first report grouped here was at 11 Nov 2026, 09:30 UTC. The headline in use is “Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Hong Kong is expanding clinical trials of histotripsy, a non-invasive treatment that uses focused ultrasound to destroy tumours, as the city seeks to establish a role in developing the technology for kidney cancer. The CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would begin trials…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?
Reported by 1 outlet
- South China Morning Post
- South China Morning PostNext-gen ultrasound cancer treatment advances: does the evidence match commercial hype?